Pancreatic Cancer Research

ResearcherThomas Jefferson UniversityActive in the last 2 years

Yaacov Richard Lawrence

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9959-2485; OpenAlex author ID A5057214962. Sources: ClinicalTrials.gov.

Their work

Papers
9 (first author 0, last author 4)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2013: 1 trial · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 9

  1. Celiac Plexus Radiosurgery for the Management of Pancreatic Cancer Pain: Key Tips and Considerations. Co-author DOI 10.1016/j.prro.2025.07.004↗
  2. A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer. Last author DOI 10.1016/j.radonc.2024.110606↗
  3. Beyond Opioids in Pancreatic Cancer: Palliative Radiotherapy and Celiac Plexus Radiosurgery. Last author DOI 10.1016/j.semradonc.2025.07.005↗
  4. Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC. Co-author DOI 10.3389/fonc.2023.1289919↗
  5. Noninvasive celiac plexus radiosurgery in palliative treatment for patients with symptomatic pancreatic cancer. Last author DOI 10.5114/wo.2021.107689↗
  6. Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study. Co-author DOI 10.1002/pds.4993↗
  7. Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG … Co-author DOI 10.1002/cncr.31058↗
  8. Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013. Last author DOI 10.6004/jnccn.2017.0138↗
  9. Conditional survival probabilities for patients with resected pancreatic adenocarcinoma. Co-author DOI 10.1097/coc.0b013e31826c62b7↗

Trials 1

  1. Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy Principal investigator NCT02324530↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Talia Golan · 5 shared papers, 2017–2025 · strength 0.62
  2. Marcin Miszczyk · 2 shared papers, 2021–2025 · strength 0.56
  3. Ross Allen Abrams · 1 shared paper, 2025 · strength 0.42
  4. Michael Yan · 1 shared paper, 2026 · strength 0.36
  5. Aisling Glynn · 1 shared paper, 2026 · strength 0.36
  6. Ariel Shimoni-Sebag · 1 shared paper, 2025 · strength 0.24
  7. Chani Stossel · 1 shared paper, 2025 · strength 0.24
  8. Jeffrey D. Goldstein · 1 shared paper, 1 shared trial, 2013–2020 · strength 0.18
  9. Galit Almog · 1 shared paper, 2023 · strength 0.15
  10. Merav Akiva Ben-David · 1 shared paper, 2023 · strength 0.15
  11. Irit Ben‐Aharon · 1 shared paper, 2023 · strength 0.15
  12. Jerzy Wydmański · 1 shared paper, 2021 · strength 0.13
  13. Ben Boursi · 1 shared paper, 2020 · strength 0.09
  14. Akram Saad · 1 shared paper, 2020 · strength 0.09
  15. Ronac Mamtani · 1 shared paper, 2020 · strength 0.09
  16. Yu‐Xiao Yang · 1 shared paper, 2020 · strength 0.09
  17. Kim A. Reiss · 1 shared paper, 2020 · strength 0.09
  18. Zvi Symon · 1 shared trial, 2013 · strength 0.09
  19. Chandan Guha · 1 shared paper, 2018 · strength 0.07
  20. William F. Regine · 1 shared paper, 2018 · strength 0.07
  21. Uri Amit · 1 shared paper, 2017 · strength 0.07
  22. Adam Paul Dicker · 1 shared paper, 2018 · strength 0.07
  23. William C. Small · 1 shared paper, 2018 · strength 0.07
  24. Christopher H. Crane · 1 shared paper, 2018 · strength 0.07
  25. Voichita Bar‐Ad · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.